If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Regulatory News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes
Get Live Data
1,554.00    30.00 (1.97%)
Bid:
1,561.00
Ask:
1,564.00
Spread: 3.00 (0.192%)
Market Cap: £3.27b
HIK Live PriceLast checked at - London Stock Exchange

Intraday Hikma Pharmaceuticals Share Chart

LTIP Awards

30 Apr 2008 15:22

Hikma Pharmaceuticals Plc30 April 2008 Hikma Pharmaceuticals PLC - LTIP Awards LONDON, 30 April 2008: Hikma Pharmaceuticals PLC (LSE: HIK) (DIFX: HIK)announces that the Remuneration Committee has made the following nil-cost awardsunder the Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan (the "LTIP")to Directors and Persons Discharging Managerial Responsibility ("PDMRs") of theCompany. Awards under the LTIP were made on 29 April 2008 at a price of £4.64 perordinary share as follows:- Name of Director/PDMR Number of LTIP SharesSaid Darwazah 90,000Mazen Darwazah 54,000Bassam Kanaan 54,000Taghreed Al-Shunnar 54,000Majda Labadi 54,000Nabil Rizk 54,000 The shares subject to the LTIP awards will only be released to the participantsin three years time, subject to their continued employment and the satisfactionof the comparative Total Shareholder Return ("TSR") performance target.Participants will only receive the full benefit of their share incentives if TSRperformance against the Comparator Group is at least at the upper quartile. - ENDS -Enquiries: Hikma Pharmaceuticals PLCHenry Knowles +44 20 7399 2760Company Secretary Susan Ringdal +44 20 7399 2760Investor Relations Director About Hikma Hikma Pharmaceuticals PLC is a fast growing multinational group focused ondeveloping, manufacturing and marketing a broad range of both branded andnon-branded generic and in-licensed pharmaceutical products. Hikma's operationsare conducted through three businesses: "Branded", "Injectables" and"Generics". Hikma's operations are based principally in the Middle East andNorth Africa ("MENA") region, where it is a market leader and sells across 17countries, the United States and Europe. In 2007, the Group achieved revenuesof $449 million (2006 $317 million) and profit attributable to shareholders was$63 million (2006 $55 million). For news and other information, please visitwww.hikma.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
16th Mar 20123:22 pmRNSDirector/PDMR Shareholding
14th Mar 20127:00 amRNSPreliminary Results
12th Mar 20127:00 amRNSHolding(s) in Company
14th Feb 20123:00 pmRNSTotal Voting Rights
2nd Feb 201211:14 amRNSHolding(s) in Company
1st Feb 20121:26 pmRNSDirector Declaration
17th Jan 201210:39 amRNSTender Offer
13th Jan 201210:16 amRNSDirector/PDMR Shareholding
12th Jan 201210:07 amRNSTotal Voting Rights
22nd Dec 201110:39 amRNSAdditional Listing
2nd Dec 201111:28 amRNSTender Offer
1st Dec 20114:14 pmRNSHolding(s) in Company
11th Nov 201111:25 amRNSTotal Voting Rights
4th Nov 20117:00 amRNSInterim Management Statement
24th Oct 20115:34 pmRNSDirector/PDMR Shareholding
18th Oct 201112:59 pmRNSDirector/PDMR Shareholding
18th Oct 201112:58 pmRNSDirector/PDMR Shareholding
18th Oct 201112:39 pmRNSDirector/PDMR Shareholding
17th Oct 20119:00 amRNSTender Offer
7th Oct 20111:14 pmRNSBlocklisting Interim Review
6th Oct 20113:26 pmRNSDividend Declaration
3rd Oct 20114:33 pmRNSAcquisition
25th Aug 20117:00 amRNSDirectorate Change
25th Aug 20117:00 amRNSInterim Results
19th Aug 20112:21 pmRNSTrading Statement
26th Jul 201110:54 amRNSTotal Voting Rights
11th Jul 20117:00 amRNSHikma enhances its API sourcing capabilities
1st Jun 20114:01 pmRNSTotal Voting Rights
26th May 201112:03 pmRNSDirector/PDMR Shareholding
25th May 20114:01 pmRNSHolding(s) in Company
17th May 20114:12 pmRNSDirector/PDMR Shareholding
13th May 20112:10 pmRNSDirector/PDMR Shareholding
13th May 20112:04 pmRNSDividend Declaration
12th May 201112:19 pmRNSAGM Statement
12th May 20117:00 amRNSInterim Management Statement
9th May 20115:45 pmRNSDirector/PDMR Shareholding
9th May 201112:04 pmRNSTotal Voting Rights
9th May 201112:01 pmRNSAnnual Information Update
3rd May 20117:00 amRNSStatement re Completion of Acquisition
15th Apr 20117:00 amRNSRe Agreement with Unimark Remedies Limited
14th Apr 20114:04 pmRNSAnnual Information Update
13th Apr 201112:07 pmRNSDirector/PDMR Shareholding
4th Apr 20112:33 pmRNSDirector/PDMR Shareholding
18th Mar 20114:05 pmRNSDirector/PDMR Shareholding
16th Mar 20117:00 amRNSPreliminary Results
2nd Mar 20119:55 amRNSTotal Voting Rights
8th Feb 201112:56 pmRNSTotal Voting Rights
3rd Feb 201110:21 amRNSHolding(s) in Company
24th Jan 20119:00 amRNSAppointments
12th Jan 20115:14 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.